ABSTRACT
Purpose
Cells modified with magnetically responsive nanoparticles (MNP) can provide the basis for novel targeted therapeutic strategies. However, improvements are required in the MNP design and cell treatment protocols to provide adequate magnetic properties in balance with acceptable cell viability and function. This study focused on select variables controlling the uptake and cell compatibility of biodegradable polymer-based MNP in cultured endothelial cells.
Methods
Fluorescent-labeled MNP were formed using magnetite and polylactide as structural components. Their magnetically driven sedimentation and uptake were studied fluorimetrically relative to cell viability in comparison to non-magnetic control conditions. The utility of surface-activated MNP forming affinity complexes with replication-deficient adenovirus (Ad) for transduction achieved concomitantly with magnetic cell loading was examined using the green fluorescent protein reporter.
Results
A high-gradient magnetic field was essential for sedimentation and cell binding of albumin-stabilized MNP, the latter being rate-limiting in the MNP loading process. Cell loading up to 160 pg iron oxide per cell was achievable with cell viability >90%. Magnetically driven uptake of MNP-Ad complexes can provide high levels of transgene expression potentially useful for a combined cell/gene therapy.
Conclusions
Magnetically responsive endothelial cells for targeted delivery applications can be obtained rapidly and efficiently using composite biodegradable MNP.
Similar content being viewed by others
Abbreviations
- Ad:
-
adenovirus
- BAEC:
-
bovine aortic endothelial cells
- BSA:
-
bovine serum albumin
- CAR:
-
Coxsackie-adenovirus receptor
- CMV:
-
cytomegalovirus
- DCC:
-
1,3-dicyclohexylcarbodiimide
- DMEM:
-
Dulbecco’s modification of Eagle’s medium
- EDC:
-
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
- FBS:
-
fetal bovine serum
- GFP:
-
green fluorescent protein
- MNP:
-
magnetic nanoparticle
- PBS:
-
phosphate buffered saline
- PLA:
-
polylactide
- SPDP:
-
N-succinimidyl 3-(2-pyridyldithio)propionate
REFERENCES
Schlorf T, Meincke M, Kossel E, Gluer CC, Jansen O, Mentlein R. Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging. Int J Mol Sci. 2011;12(1):12–23.
Sykova E, Jendelova P, Herynek V. MR tracking of stem cells in living recipients. Methods Mol Biol. 2009;549:197–215.
Pislaru SV, Harbuzariu A, Agarwal G, Witt T, Gulati R, Sandhu NP, et al. Magnetic forces enable rapid endothelialization of synthetic vascular grafts. Circulation. 2006;114(1 Suppl):I314–8.
Pislaru SV, Harbuzariu A, Gulati R, Witt T, Sandhu NP, Simari RD, et al. Magnetically targeted endothelial cell localization in stented vessels. J Am Coll Cardiol. 2006;48(9):1839–45.
Kyrtatos PG, Lehtolainen P, Junemann-Ramirez M, Garcia-Prieto A, Price AN, Martin JF, et al. Magnetic tagging increases delivery of circulating progenitors in vascular injury. JACC Cardiovasc Interv. 2009;2(8):794–802.
Hofmann A, Wenzel D, Becher UM, Freitag DF, Klein AM, Eberbeck D, et al. Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc Natl Acad Sci U S A. 2009;106(1):44–9.
Polyak B, Fishbein I, Chorny M, Alferiev I, Williams D, Yellen B, et al. High field magnetic gradients can target magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc Natl Acad Sci U S A. 2008;105(2):698–703.
Shimizu K, Ito A, Arinobe M, Murase Y, Iwata Y, Narita Y, et al. Effective cell-seeding technique using magnetite nanoparticles and magnetic force onto decellularized blood vessels for vascular tissue engineering. J Biosci Bioeng. 2007;103(5):472–8.
Muthana M, Scott SD, Farrow N, Morrow F, Murdoch C, Grubb S, et al. A novel magnetic approach to enhance the efficacy of cell-based gene therapies. Gene Ther. 2008;15(12):902–10.
Fishbein I, Chorny M, Levy RJ. Site-specific gene therapy for cardiovascular disease. Curr Opin Drug Discov Devel. 2010;13(2):203–13.
Soenen SJ, Himmelreich U, Nuytten N, De Cuyper M. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials. 2010;32(1):195–205.
Nyanguile O, Dancik C, Blakemore J, Mulgrew K, Kaleko M, Stevenson SC. Synthesis of adenoviral targeting molecules by intein-mediated protein ligation. Gene Ther. 2003;10(16):1362–9.
Chorny M, Fishbein I, Alferiev IS, Nyanguile O, Gaster R, Levy RJ. Adenoviral gene vector tethering to nanoparticle surfaces results in receptor-independent cell entry and increased transgene expression. Mol Ther. 2006;14(3):382–91.
Chorny M, Polyak B, Alferiev IS, Walsh K, Friedman G, Levy RJ. Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles. FASEB J. 2007;21(10):2510–9.
Chorny M, Fishbein I, Alferiev I, Levy RJ. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. Mol Pharm. 2009;6(5):1380–7.
Chorny M, Fishbein I, Yellen BB, Alferiev IS, Bakay M, Ganta S, et al. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proc Natl Acad Sci U S A. 2010;107(18):8346–51.
Wilhelm C, Gazeau F, Bacri JC. Rotational magnetic endosome microrheology: viscoelastic architecture inside living cells. Phys Rev E Stat Nonlin Soft Matter Phys. 2003;67(6 Pt 1):061908.
Tresilwised N, Pithayanukul P, Mykhaylyk O, Holm PS, Holzmuller R, Anton M, et al. Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force. Mol Pharm. 2010;7(4):1069–89.
Tresilwised N, Pithayanukul P, Holm PS, Schillinger U, Plank C, Mykhaylyk O. Effects of nanoparticle coatings on the activity of oncolytic adenovirus-magnetic nanoparticle complexes. Biomaterials. 2012;33(1):256–69.
Mah C, Fraites Jr TJ, Zolotukhin I, Song S, Flotte TR, Dobson J, et al. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. Mol Ther. 2002;6(1):106–12.
Chorny M, Fishbein I, Levy RJ. Endothelial cells transduced with magnetically responsive nanoparticles formulated with iNOS encoding adenovirus inhibit proliferation of aortic smooth muscle cells in a direct co-culture model. Mol Ther. 2009;17:S393.
Huth S, Lausier J, Gersting SW, Rudolph C, Plank C, Welsch U, et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med. 2004;6(8):923–36.
Chorny M, Fishbein I, Forbes S, Alferiev I. Magnetic nanoparticles for targeted vascular delivery. IUBMB Life. 2011;63(8):613–20.
Kempe H, Kates SA, Kempe M. Nanomedicine’s promising therapy: magnetic drug targeting. Expert Rev Med Devices. 2011;8(3):291–4.
Astete CE, Sabliov CM. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed. 2006;17(3):247–89.
Chorny M, Fishbein I, Danenberg HD, Golomb G. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. J Control Release. 2002;83(3):389–400.
ACKNOWLEDGMENTS & DISCLOSURES
This research was supported in part by grants from the NIH (HL72108 and HL94816), the American Heart Association (Scientist Development Grant 10SDG4020003), the Nanotechnology Institute and the William J. Rashkind Endowment of The Children’s Hospital of Philadelphia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chorny, M., Alferiev, I.S., Fishbein, I. et al. Formulation and In Vitro Characterization of Composite Biodegradable Magnetic Nanoparticles for Magnetically Guided Cell Delivery. Pharm Res 29, 1232–1241 (2012). https://doi.org/10.1007/s11095-012-0675-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-012-0675-y